Current status and future trends of the pharmaceutical circulation industry
There are generally three links in the field of drug circulation in the country, namely, drug wholesale links, drug retail enterprises, and hospital outpatient pharmacies. With the improvement of people's medical consumption level and the expansion of the pharmaceutical market, the scale of the pharmaceutical circulation industry has also maintained rapid growth. At the same time, the competitive trend of the pharmaceutical circulation industry has not weakened, and the market giants of the industry giants have become more fierce.
2017, the pharmaceutical circulation industry mainly presents six major characteristics
Looking back at the development of the pharmaceutical circulation industry in 2017, we can see that under the circumstances of the full implementation of the "two-vote system", the concentration of the pharmaceutical circulation industry has obviously accelerated, and leading enterprises have benefited. Some experts pointed out that 2017 is a year of dramatic changes in the circulation structure of Chinese medicine. In this year, the pharmaceutical circulation industry mainly showed six major characteristics.
First, the retail chain of drugs. China's retail drug chain rate has a large room for improvement. Some listed chain enterprises are using the power of capital to accelerate the expansion in the critical period of industry concentration.
Second, the outflow of prescription drugs releases the billion-dollar market. With the medical reform policies such as the separation of medicines, the reduction of medicines, and the two-vote system, the outflow of prescriptions is the trend of the times. Not only 2017, but also the market of 100 billion yuan will be released in the future.
Third, the concentration of pharmaceutical business has further improved. In 2017, the “two-vote system†was fully implemented. Under the influence of this, the concentration of the pharmaceutical circulation industry was significantly accelerated, and the circulation of medicines was further compressed, and the industrial concentration was better improved.
Fourth, the consistency evaluation of reshuffle pharmaceutical companies. According to statistics, at present, the total number of drug approval documents in China has reached 189,000. After the consistency evaluation, small and medium-sized pharmaceutical companies and R&D institutions with weak research and development capabilities can still avoid the fate of being eliminated.
Fifth, the pharmaceutical e-commerce welcomes the policy and develops rapidly. At the national policy level, the entry system has actually lowered the threshold for pharmaceutical companies to conduct e-commerce business.
Sixth, the "three medical linkages" runs through the linkage reform of the entire industry chain. “Three medicines†refers to medical , medical insurance, and medical reforms, and the entire industry chain is the core of medical reform.
2018, 4 major trends may penetrate the pharmaceutical circulation industry
According to the trend of pharmaceutical circulation in 2017, some insiders have also predicted the trend of 2018, and pointed out that some changes and results will be displayed in 2018. The author was informed that in 2018, the pharmaceutical circulation industry mainly has the following trends.
First, the trend of flattening the supply chain is significant. In the past, the circulation form and management system of pharmaceuticals at the level of distribution have not met the policy requirements and market orientation, and industrial pharmaceutical companies and large-scale commercial pharmaceutical companies will become the direct promoters of the flat management of the pharmaceutical supply chain.
Second, information technology is labeled "wisdom." Smart information technology will become more humanized in the field of Chinese medicine and health, and the distance from the public will also shrink. This is also expected to become the basic technology to support enterprise management, and will continue to develop around the health needs of “peopleâ€. .
Third, third-party logistics began to make a profit. In fact, the implementation of the “two-vote system†gave the opportunity for the growth of the three-party logistics of medicines.
Fourth, as in 2017, the widening of medical e-commerce will become the norm.
Although the industry has analyzed the trend of pharmaceutical circulation in 2018, the author also understands that at present, the concentration of China's pharmaceutical industry is still low, there are many circulation links and high costs, and there is still a drug from producer to final consumer. From 6 to 7 circulation links, the phenomenon of disorderly competition and excessive competition is still serious. In this regard, the relevant pharmaceutical circulation enterprises need to be prepared to solve the problems of the enterprise itself, so as to break through the trend in a complex environment.
The author was informed that some companies, such as Guokong, China Resources, Shanghai Pharmaceuticals, and Jiuzhoutong, have formulated their corporate development strategies based on actual conditions. The state control is based on the integration of batch and zero; China Resources is mainly based on mergers and acquisitions, industrial and commercial cooperation and linkage; Shanghai Pharmaceuticals seizes the opportunity of industrial innovation and achieves the goal of corporate performance growth; Kyushu General focuses on consumer goods and fosters growth in corporate performance. New highlights.
Conclusion:
It can be foreseen that under the influence of policy factors such as two-vote system and generic drug consistency evaluation, the industry concentration in the field of pharmaceutical circulation will continue to increase in 2018, and competition among enterprises, especially among leading enterprises, will become more intense. In this regard, both large enterprises and small and medium-sized enterprises need to respond to the national policy at the same time, combined with the actual situation, give full play to their own advantages, and find new breakthrough points to face the industry exam.
Food Phosphate,Food Grade Sodium Tripolyphosphate,Sodium Tripolyphosphate Food,Polyols Erythritol
Shanghai J.Shine Co.,Ltd , https://www.jshinechem.com